There has been much speculation about how ACE inhibitors or ARBs might alter expression of the ACE2 protein, and thereby potentially alter host susceptibility to infection with SARS-CoV-2 or the progression, severity, and tissue-specific pathology of COVID-19. This evidence concerns the gene ACE2 and COVID-19.